Quantbot Technologies LP Hutchmed (China) LTD Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$11.85 - $16.95 $8,295 - $11,865	700 New	700 $11,000
Q1 2023 May 12, 2023	SELL	$13.02 - $19.87 $38,890 - $59,351	-2,987 Reduced 43.86%	3,824 $49,000
Q4 2022 Feb 13, 2023	BUY	$7.65 - $15.51 $52,104 - $105,638	6,811 New	6,811 $100,000
Q2 2022 Aug 09, 2022	SELL	$8.59 - $20.77 $20,152 - $48,726	-2,346 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.52 - $35.65 $36,409 - $83,634	2,346 New	2,346 $44,000

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.